Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (683)	5/11/1999 6:11:00 PM
From: limit	Respond to of 1139

opalapril, I don't know about XOMA, but you are correct in ICOS. I bought into ICOS beginning in 1996 (my initial price was $8). The stock was recommended to me from an older guy that worked with Rathmann at 3M in I believe the late 1950's. He told me that he could see the guy was a genius and a class guy. That older guy has made a fortune in both AMGN and ICOS. Regards limit

To: opalapril who wrote (683)	5/11/1999 6:51:00 PM
From: Edscharp	Respond to of 1139

Opal, I see no point in arguing with you if your going to confuse the issues with facts. <g>

To: opalapril who wrote (683)	5/11/1999 7:07:00 PM
From: Edscharp	Respond to of 1139

<<Xoma doesn't zoom and they may have an important product in the very near future>> Opal, I will concede I picked a bad example to make my point. But, in all seriousness how about all the other (potentially) great biotechs that aren't zooming. I'll make it a short list: Isis Pharmacy, Vical, Inhale Therapeutics, Ligand, Vertex Pharmaceutical and many others. In most cases the above companies have important products in Phase III trials, but still no zoom. I propose the following experiment. I will change my name to Bill Gates and buy 10% of Isis Pharmacy and we'll see what happens. Uh, Errr,.....can you loan me $25M?